Date
Time
Speakers: Allison P. Wheeler, MD, MSCI; Angela C. Weyand, MD; Dr. Keri Norris, PhD, MPH, MCHES
Description: Access to care too often depends on who you are or where you live. Join NBDF and the Hemostasis & Thrombosis Research Society (HTRS) for an engaging Research Journal Club discussion with leaders in health access and clinical care and community lived experience experts. We'll address critical health equity challenges in bleeding disorders care, including barriers faced by women, girls, and other underserved community members. The Journal Club format is a learning conversation, not just a presentation. We invite you to dive into the selected publications ahead of time and come ready to ask questions, share experiences, and engage with our speakers during our live Q&A.
Pre-reads:
- From Vision to Action: NBDF's Roadmap for Achieving Health Equity, Diversity, and Inclusion
- Trends for Dedicated Care for Females with Bleeding Disorders within U.S. Hemophilia Treatment Centers (PubMed)
- Sexism in the Management of Bleeding Disorders (PubMed)
Allison P. Wheeler, MD, MSCI, received her medical training at the University of Massachusetts and pediatric residency training at Baystate Medical Center. She completed her pediatric hematology/oncology and transfusion medicine fellow training at Vanderbilt University Medical Center. She worked as faculty in pediatrics and pathology at Vanderbilt from 2014-2024 splitting her clinical time between pediatric patients with hemostatic and thrombotic disorders and as the co-medical director of the coagulation laboratory. She was the director of research for benign hematology at Vanderbilt with a robust collaborative research portfolio and a personal research interest in females with heavy menstrual bleeding. Her academic work has expanded to also include investigation of diversity, equity, and inclusion in medicine. Allison transitioned to a position as the scientific director at the Washington Center for Bleeding Disorders and associate professor at the University of Washington in August 2024.
Dr. Keri Norris, PhD, MPH, MCHES, is the senior vice president of health access and strategic innovation at NBDF, where she leads the development of a health equity framework, linguistically and culturally responsive programs, and initiatives to reduce disparities in the bleeding disorders community. With over 25 years of experience in health equity, women's health, and addressing health disparities, Dr. Norris has held senior leadership roles at the CDC, Morehouse School of Medicine, the University of South Carolina, and The Fulton-DeKalb Hospital Authority.
She is the author of the influential framework "From Vision to Action: NBDF’s Roadmap for Achieving Health Equity, Diversity, and Inclusion" and she gave the TEDx Talk "Hiding in Plain Sight: What’s Missing in Health Equity."
Dr. Norris holds a PhD in health promotion, education, and behavior; a Juris Master in health law, policy, and regulation; an MPH in health administration, management and policy; a graduate certificate in women & gender studies; and a BA in Africana studies. She is also a master certified health education specialist and has completed advanced training at the University of Michigan and Cornell University.
Angela C. Weyand, MD, is a native of Kansas City, KS, and a graduate of Northwestern University in Evanston, IL. She attended medical school at the University of Michigan and completed her Pediatrics residency at the University of Washington/Seattle Children's Hospital. She then returned to the University of Michigan for Pediatric Hematology and Oncology fellowship and subsequently stayed on as faculty. Her clinical and research interests are in young women and girls with hemostatic and thrombotic disorders, Von Willebrand disease, iron deficiency, and health equity. She is co-director of a combined hematology/gynecology program and pediatric clinical director of the University of Michigan Hemophilia Treatment Center. She was co-chair of the National Bleeding Disorders Foundation (NBDF) working group to identify a national research blueprint to address the needs of women and girls and those with the potential to menstruate, a member of the ASH Von Willebrand Disease management guidelines and ASH Iron Deficiency Diagnosis guidelines, chair of the ASH Working group on Iron Deficiency, a co-chair of the ISTH Women’s Health SSC, and a section lead on the Lancet Haematology Women’s Health Commission.